EI
EAM Investors Portfolio holdings
AUM
$660M
1-Year Return
271.72%
This Quarter Return
+15.21%
1 Year Return
+271.72%
3 Year Return
+5,059.16%
5 Year Return
+72,876.1%
10 Year Return
+9,525,914.37%
AUM
$378M
AUM Growth
-$30.8M
(-7.5%)
Cap. Flow
-$33M
Cap. Flow
% of AUM
-8.72%
Top 10 Holdings %
Top 10 Hldgs %
10.62%
Holding
337
New
95
Increased
51
Reduced
79
Closed
108
Top Buys
| 1 |
CUTR
Cutera, Inc.
CUTR
|
+$4.26M |
| 2 |
Addus HomeCare
ADUS
|
+$3.19M |
| 3 |
PennyMac Financial
PFSI
|
+$3.11M |
| 4 |
EverQuote
EVER
|
+$3.07M |
| 5 |
Independence Realty Trust
IRT
|
+$2.95M |
Top Sells
| 1 |
Napco Security Technologies
NSSC
|
+$3.72M |
| 2 |
NeoGenomics
NEO
|
+$3.62M |
| 3 |
NMI Holdings
NMIH
|
+$3.44M |
| 4 |
EVRI
Everi Holdings
EVRI
|
+$3.34M |
| 5 |
Freshpet
FRPT
|
+$3.17M |
Sector Composition
| 1 | Technology | 25.79% |
| 2 | Healthcare | 23.79% |
| 3 | Industrials | 13.71% |
| 4 | Consumer Discretionary | 12.39% |
| 5 | Financials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ODT
201
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $822K | 0.22% |
+31,564
| New | +$822K |
|
|
ACHN
202
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $796K | 0.21% |
+221,011
| New | +$796K |
|
203
Kura Sushi USA
KRUS
$964M
| $770K | 0.2% |
+39,268
| New | +$770K |
|
|
RETA
204
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $735K | 0.19% |
9,150
-19,783
| -68% | -$1.59M |
|
|
ENZ
205
DELISTED
Enzo Biochem, Inc.
ENZ
| $734K | 0.19% |
203,962
+25,023
| +14% | +$90.1K |
|
206
Viemed Healthcare
VMD
$263M
| $731K | 0.19% |
+105,951
| New | +$731K |
|
|
RADA
207
DELISTED
Rada Electronic Industries Ltd
RADA
| $674K | 0.18% |
+141,640
| New | +$674K |
|
|
SILV
208
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $672K | 0.18% |
128,675
-63,634
| -33% | -$332K |
|
|
ATXI
209
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
| $669K | 0.18% |
100
+33
| +49% | +$221K |
|
210
LGL Group
LGL
$35.2M
| $668K | 0.18% |
+172,245
| New | +$668K |
|
211
Ovid Therapeutics
OVID
$89.6M
| $668K | 0.18% |
+206,118
| New | +$668K |
|
|
SAFE
212
DELISTED
Safehold Inc.
SAFE
| $662K | 0.18% |
21,717
-24,419
| -53% | -$744K |
|
213
XBiotech
XBIT
$83.8M
| $660K | 0.17% |
63,108
+1,781
| +3% | +$18.6K |
|
214
Inseego
INSG
$200M
| $658K | 0.17% |
13,716
-20,409
| -60% | -$979K |
|
215
Arcturus Therapeutics
ARCT
$470M
| $654K | 0.17% |
+63,640
| New | +$654K |
|
|
CTHR
216
DELISTED
Charles & Colvard Ltd
CTHR
| $654K | 0.17% |
40,102
+992
| +3% | +$16.2K |
|
|
ZIXI
217
DELISTED
Zix Corporation
ZIXI
| $647K | 0.17% |
89,332
-324,175
| -78% | -$2.35M |
|
218
Castle Biosciences
CSTL
$621M
| $615K | 0.16% |
+34,005
| New | +$615K |
|
219
Quanterix
QTRX
$224M
| $615K | 0.16% |
28,002
-12,525
| -31% | -$275K |
|
220
Victory Capital Holdings
VCTR
$4.58B
| $615K | 0.16% |
40,010
-43,598
| -52% | -$670K |
|
221
Intellicheck
IDN
$113M
| $609K | 0.16% |
122,080
+3,481
| +3% | +$17.4K |
|
|
222
Napco Security Technologies
NSSC
$1.5B
| $609K | 0.16% |
47,700
-291,756
| -86% | -$3.72M |
|
223
Fate Therapeutics
FATE
$111M
| $599K | 0.16% |
38,540
-32,259
| -46% | -$501K |
|
|
MSON
224
DELISTED
Misonix Inc
MSON
| $593K | 0.16% |
29,500
-54,880
| -65% | -$1.1M |
|
|
CDMO
225
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $589K | 0.16% |
+111,208
| New | +$589K |
|